Allergic rhinitis
Conditions
Interventions
Sham group:10% Yu-Ping-Feng Nasal Spray
Experimental group:Yu-Ping-Feng Nasal Spray
Sponsors
Hospital of Chengdu University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: (1) Patients who meet the diagnostic criteria of both traditional Chinese and Western medicine; (2) Aged between 18 and 65 years regardless of gender; (3) Have not received any medication for AR in the past two weeks; (4) Have normal cognitive function agree to voluntarily participate in this trial and sign the informed consent form; (5) All patients and accompanying family members are aware of and understand the purpose significance and process of this research project.
Exclusion criteria
Exclusion criteria: (1) Patients who do not meet the diagnostic or inclusion criteria; (2) Patients with severe nasal septum deviation chronic rhinosinusitis bronchial asthma nasal polyps or other related diseases; (3) Patients with severe dysfunction of the heart liver kidneys or other organs or those with autoimmune diseases; (4) Patients with mental illness intellectual disabilities or other conditions that prevent them from cooperating with the trial; (5) Patients who are pregnant breastfeeding or planning to conceive; (6) Patients with major neurological or psychiatric disorders that prevent them from taking medication regularly; (7) Patients with known allergies to any component of the investigational drug; (8) Patients who have participated in other clinical studies within the past two months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Nasal symptom score; | — |
Secondary
| Measure | Time frame |
|---|---|
| TCM Syndrome score;Transforming growth factor beta 1;Symptom score;Rhinoconjunctivitis quality of life scale;Interleukin 10;Interleukin 17; | — |
Countries
China
Contacts
Public ContactLi Tian
Hospital of Chengdu University of Traditional Chinese Medicine
Outcome results
None listed